Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors

Journal of Child Neurology

Volumn 23, Issue 10, 2008, Pages 1221-1230

  Tye, Sandra L ^a   Gilg, Anne G ^a   Tolliver, Lauren B ^a   Wheeler, William G ^a   Toole, Bryan B ^b   Maria, Bernard L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Ceruloplasmin; Glioma; Glycosaminoglycan; Hyaluronan; Stem like cells

Indexed keywords

CERULOPLASMIN; HYALURONIC ACID; HYALURONIC ACID OLIGOMER; OLIGOMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER STEM CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RAT; SPINAL CORD TUMOR; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANTIGENS, CD44; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CERULOPLASMIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX; FEMALE; GLIOMA; HUMANS; HYALURONIC ACID; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD NEOPLASMS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 53549122213     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808321066     Document Type: Conference Paper

References (60)

1. Fortna RR, Watson HA, Nyquist SE Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions Biol Reprod. 1999; 61: 1042-1049.
2. Klomp LW, Gitlin JD Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet. 1996; 5: 1989-1996.
3. Patel BN, David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem. 1997; 272: 20185-20190.
4. Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem. 2000; 275: 4305-4310.
5. Salzer JL, Lovejoy L., Linder MC, et al. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci Res. 1998; 54: 147-157.
6. Park YS, Suzuki K., Taniguchi N., et al. Glutathione peroxidase-like activity of caeruloplasmin as an important lung antioxidant. FEBS Lett. 1999; 458: 133-136.
7. Hellman NE, Gitlin JD Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002; 22: 439-458.
8. Messerschmidt A., Rossi A., Ladenstein R., et al. X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol. 1989; 206: 513-529.
9. Osaki S., Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem. 1966; 241: 2746-2751.
10. Osaki S., Johnson DA, Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem. 1971; 246: 3018-3023.
11. Bielli P., Calabrese L. Structure to function relationships in ceruloplasmin: A 'moonlighting' protein. Cell Mol Life Sci. 2002; 59: 1413-1427.
12. Laurell CB, Kullander S., Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest. 1968; 21: 337-343.
13. Hough CD, Cho KR, Zonderman AB, et al. Coordinately up-regulated genes in ovarian cancer. Cancer Res. 2001; 61: 3869-3876.
14. Kunapuli SP, Singh H., Singh P., et al. Ceruloplasmin gene expression in human cancer cells. Life Sci. 1987; 40: 2225-2228.
15. Stassar MJ, Devitt G., Brosius M., et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer. 2001; 85: 1372-1382.
16. Manjula S., Aroor AR, Raja A., et al. Elevation of serum ceruloplasmin levels in brain tumours. Acta Neurol Scand. 1992; 86: 156-158.
17. Conley L., Geurs TL, Levin LA Transcriptional regulation of ceruloplasmin by an IL-6 response element pathway. Brain Res Mol Brain Res. 2005; 139: 235-241.
18. di Patti MC, Persichini T., Mazzone V., et al. Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis. Neurosci Lett. 2004; 363: 182-186.
19. Knapp J., Olson L., Tye S., et al. Case of desmoplastic infantile ganglioglioma secreting ceruloplasmin. J Child Neurol. 2005; 20: 920-924.
20. Al-Hajj M., Clarke MF Self-renewal and solid tumor stem cells. Oncogene. 2004; 23: 7274-7282.
21. Caussinus E., Hirth F. Asymmetric stem cell division in development and cancer. Prog Mol Subcell Biol. 2007; 45: 205-225.
22. Singh SK, Clarke ID, Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63: 5821-5828.
23. Soltysova A., Altanerova V., Altaner C. Cancer stem cells. Neo-plasma. 2005; 52: 435-440.
24. Turley EA, Noble PW, Bourguignon LY Signaling properties of hyaluronan receptors. J Biol Chem. 2002; 277: 4589-4592.
25. Toole BP Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer. 2004; 4:528-539.
26. Ranuncolo SM, Ladeda V., Specterman S., et al. CD44 expression in human gliomas. J Surg Oncol. 2002; 79: 30-35; discussion 35-36.
27. Bouvier-Labit C., Liprandi A., Monti G., et al. CD44H is expressed by cells of the oligodendrocyte lineage and by oligodendrogliomas in humans. J Neurooncol. 2002; 60: 127-134.
28. Toole BP Hyaluronan in morphogenesis. Semin Cell Dev Biol. 2001; 12: 79-87.
29. Knudson W., Chow G., Knudson CB CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002; 21: 15-23.
30. Goodell MA, Brose K., Paradis G., et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996; 183:1797-1806.
31. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A. 2004; 101: 781-786.
32. Galli R., Binda E., Orfanelli U., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64: 7011 - 7021.
33. Zeng C., Toole BP, Kinney SD, et al. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer. 1998; 77: 396-401.
34. Muir D., Johnson J., Rojiani M., et al. Assessment of lamininmediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord. J Neurooncol. 1996; 30: 199-211.
35. Gilg AG, Tye SL, Tolliver LB, et al. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors Clin Cancer Res. 2008; 14:1804-1813.
36. Bao S., Wu Q., McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444: 756-760.
37. Liu G., Yuan X., Zeng Z., et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006; 5: 67.
38. Lo HW, Day CP, Hung MC Cancer-specific gene therapy. Adv Genet. 2005; 54: 235-255.
39. Lee CM, Lo HW, Shao RP, et al. Selective activation of ceruloplasmin promoter in ovarian tumors: Potential use for gene therapy. Cancer Res. 2004; 64: 1788-1793.
40. Kluger HM, Kluger Y., Gilmore-Hebert M., et al. cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model. Lab Invest. 2004; 84: 320-331.
41. Kwok JC, Richardson DR The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol. 2002; 42: 65-78.
42. Elstner A., Holtkamp N., von Deimling A. Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells. Clin Exp Metastasis. 2007; 24: 57-66.
43. Kato M., Seki N., Sugano S., et al. Identification of sonic hedgehog-responsive genes using cDNA microarray. Biochem Biophys Res Commun. 2001; 289: 472-478.
44. Bar EE, Chaudhry A., Lin A., et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007: 2007-0166.
45. Ghatak S., Misra S., Toole BP Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem. 2002; 277: 38013-38020.
46. Itano N., Atsumi F., Sawai T., et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A. 2002; 99: 3609-3614.
47. Sohara Y., Ishiguro N., Machida K., et al. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogenactivated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell. 2001; 12: 1859-1868.
48. Ward JA, Huang L., Guo H., et al. Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol. 2003; 162: 1403-1409.
49. Dehnhardt M., Zoriy MV, Khan Z., et al. Element distribution is altered in a zone surrounding human glioblastoma multiforme. J Trace Elem Med Biol. 2008; 22: 17-23.
50. Brem S., Grossman SA, Carson KA, et al. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol. 2005; 7: 246-253.
51. Donate F., Juarez JC, Burnett ME, et al. Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224). Br J Cancer. 2008; 98: 776-783.
52. Lowndes SA, Harris AL The role of copper in tumour angiogenesis J Mammary Gland Biol Neoplasia. 2005; 10: 299-310.
53. Mazumder B., Fox PL Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: Role of the 3' untranslated region. Mol Cell Biol. 1999; 19: 6898-6905.
54. Mukhopadhyay CK, Mazumder B., Fox PL Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency J Biol Chem. 2000; 275: 21048-21054.
55. Das D., Tapryal N., Goswami SK, et al. Regulation of ceruloplasmin in human hepatic cells by redox active copper: Identification of a novel AP-1 site in the ceruloplasmin gene. Biochem J. 2007; 402: 135-141.
56. Comerford KM, Wallace TJ, Karhausen J., et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002; 62:3387-3394.
57. Keith B., Simon MC Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129: 465-472.
58. Irie N., Matsuo T., Nagata I. Protocol of radiotherapy for glioblastoma according to the expression of HIF-1. Brain Tumor Pathol. 2004; 21: 1-6.
59. Lee KH, Yun SJ, Nam KN, et al. Activation of microglial cells by ceruloplasmin. Brain Res. 2007; 1171: 1-8.
60. Sarkaria JN, Carlson BL, Schroeder MA, et al. Use of an ortho-topic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res. 2006; 12: 2264-2271.